106 related articles for article (PubMed ID: 30440488)
21. Diffusion-weighted magnetic resonance imaging for pretreatment prediction and monitoring of treatment response of patients with locally advanced breast cancer undergoing neoadjuvant chemotherapy.
Nilsen L; Fangberget A; Geier O; Olsen DR; Seierstad T
Acta Oncol; 2010 Apr; 49(3):354-60. PubMed ID: 20397769
[TBL] [Abstract][Full Text] [Related]
22. DCE-MRI Texture Features for Early Prediction of Breast Cancer Therapy Response.
Thibault G; Tudorica A; Afzal A; Chui SY; Naik A; Troxell ML; Kemmer KA; Oh KY; Roy N; Jafarian N; Holtorf ML; Huang W; Song X
Tomography; 2017 Mar; 3(1):23-32. PubMed ID: 28691102
[TBL] [Abstract][Full Text] [Related]
23. Texture Analysis with 3.0-T MRI for Association of Response to Neoadjuvant Chemotherapy in Breast Cancer.
Eun NL; Kang D; Son EJ; Park JS; Youk JH; Kim JA; Gweon HM
Radiology; 2020 Jan; 294(1):31-41. PubMed ID: 31769740
[TBL] [Abstract][Full Text] [Related]
24. The assessment of breast cancer response to neoadjuvant chemotherapy: comparison of magnetic resonance imaging and 18F-fluorodeoxyglucose positron emission tomography.
Park JS; Moon WK; Lyou CY; Cho N; Kang KW; Chung JK
Acta Radiol; 2011 Feb; 52(1):21-8. PubMed ID: 21498321
[TBL] [Abstract][Full Text] [Related]
25. Dynamic Contrast-enhanced Breast MRI for Evaluating Residual Tumor Size after Neoadjuvant Chemotherapy.
Kim SY; Cho N; Park IA; Kwon BR; Shin SU; Kim SY; Lee SH; Chang JM; Moon WK
Radiology; 2018 Nov; 289(2):327-334. PubMed ID: 30152744
[TBL] [Abstract][Full Text] [Related]
26. Comparison of Pathologic Response Evaluation Systems After Neoadjuvant Chemotherapy in Breast Cancers: Correlation With Computer-Aided Diagnosis of MRI Features.
Choi WJ; Kim HH; Cha JH; Shin HJ; Chae EY
AJR Am J Roentgenol; 2019 Oct; 213(4):944-952. PubMed ID: 31237439
[No Abstract] [Full Text] [Related]
27. Comparing the Performances of Magnetic Resonance Imaging Size vs Pharmacokinetic Parameters to Predict Response to Neoadjuvant Chemotherapy and Survival in Patients With Breast Cancer.
Dogan BE; Yuan Q; Bassett R; Guvenc I; Jackson EF; Cristofanilli M; Whitman GJ
Curr Probl Diagn Radiol; 2019; 48(3):235-240. PubMed ID: 29685400
[TBL] [Abstract][Full Text] [Related]
28. Predicting survival and early clinical response to primary chemotherapy for patients with locally advanced breast cancer using DCE-MRI.
Johansen R; Jensen LR; Rydland J; Goa PE; Kvistad KA; Bathen TF; Axelson DE; Lundgren S; Gribbestad IS
J Magn Reson Imaging; 2009 Jun; 29(6):1300-7. PubMed ID: 19472387
[TBL] [Abstract][Full Text] [Related]
29. Pretreatment prediction of pathologic complete response to neoadjuvant chemotherapy in breast cancer: Perfusion metrics of dynamic contrast enhanced MRI.
Lee J; Kim SH; Kang BJ
Sci Rep; 2018 Jun; 8(1):9490. PubMed ID: 29934524
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of the efficacy of neoadjuvant chemotherapy for breast cancer using diffusion-weighted imaging and dynamic contrast-enhanced magnetic resonance imaging.
Xu HD; Zhang YQ
Neoplasma; 2017; 64(3):430-436. PubMed ID: 28253722
[TBL] [Abstract][Full Text] [Related]
31. Early Prediction and Evaluation of Breast Cancer Response to Neoadjuvant Chemotherapy Using Quantitative DCE-MRI.
Tudorica A; Oh KY; Chui SY; Roy N; Troxell ML; Naik A; Kemmer KA; Chen Y; Holtorf ML; Afzal A; Springer CS; Li X; Huang W
Transl Oncol; 2016 Feb; 9(1):8-17. PubMed ID: 26947876
[TBL] [Abstract][Full Text] [Related]
32. Tumor texture parameters of invasive ductal breast carcinoma in neoadjuvant chemotherapy: early identification of non-responders on breast MRI.
Nadrljanski MM; Milosevic ZC
Clin Imaging; 2020 Sep; 65():119-123. PubMed ID: 32446129
[TBL] [Abstract][Full Text] [Related]
33. Breast MRI during lactation: effects on tumor conspicuity using dynamic contrast-enhanced (DCE) in comparison with diffusion tensor imaging (DTI) parametric maps.
Nissan N; Allweis T; Menes T; Brodsky A; Paluch-Shimon S; Haas I; Golan O; Miller Y; Barlev H; Carmon E; Brodsky M; Anaby D; Lawson P; Halshtok-Neiman O; Shalmon A; Gotlieb M; Faermann R; Konen E; Sklair-Levy M
Eur Radiol; 2020 Feb; 30(2):767-777. PubMed ID: 31529255
[TBL] [Abstract][Full Text] [Related]
34. Monitoring response to primary chemotherapy in breast cancer using dynamic contrast-enhanced magnetic resonance imaging.
Martincich L; Montemurro F; De Rosa G; Marra V; Ponzone R; Cirillo S; Gatti M; Biglia N; Sarotto I; Sismondi P; Regge D; Aglietta M
Breast Cancer Res Treat; 2004 Jan; 83(1):67-76. PubMed ID: 14997056
[TBL] [Abstract][Full Text] [Related]
35. Magnetic resonance imaging evaluation of residual tumors in breast cancer after neoadjuvant chemotherapy: surgical implications.
Zhou J; Li G; Sheng F; Qiao P; Zhang H; Xing X
Acta Radiol; 2016 May; 57(5):529-37. PubMed ID: 26231950
[TBL] [Abstract][Full Text] [Related]
36. Prognostic value of DCE-MRI in breast cancer patients undergoing neoadjuvant chemotherapy: a comparison with traditional survival indicators.
Pickles MD; Lowry M; Manton DJ; Turnbull LW
Eur Radiol; 2015 Apr; 25(4):1097-106. PubMed ID: 25424563
[TBL] [Abstract][Full Text] [Related]
37. Radiomic analysis of DCE-MRI for prediction of response to neoadjuvant chemotherapy in breast cancer patients.
Fan M; Wu G; Cheng H; Zhang J; Shao G; Li L
Eur J Radiol; 2017 Sep; 94():140-147. PubMed ID: 28712700
[TBL] [Abstract][Full Text] [Related]
38. AG-013736, a novel inhibitor of VEGF receptor tyrosine kinases, inhibits breast cancer growth and decreases vascular permeability as detected by dynamic contrast-enhanced magnetic resonance imaging.
Wilmes LJ; Pallavicini MG; Fleming LM; Gibbs J; Wang D; Li KL; Partridge SC; Henry RG; Shalinsky DR; Hu-Lowe D; Park JW; McShane TM; Lu Y; Brasch RC; Hylton NM
Magn Reson Imaging; 2007 Apr; 25(3):319-27. PubMed ID: 17371720
[TBL] [Abstract][Full Text] [Related]
39. A computer-aided diagnosis (CAD) scheme for pretreatment prediction of pathological response to neoadjuvant therapy using dynamic contrast-enhanced MRI texture features.
Giannini V; Mazzetti S; Marmo A; Montemurro F; Regge D; Martincich L
Br J Radiol; 2017 Aug; 90(1077):20170269. PubMed ID: 28707546
[TBL] [Abstract][Full Text] [Related]
40. Magnetic resonance imaging enhancement features before and after neoadjuvant chemotherapy in patients with breast cancer: a predictive value for responders.
Kang DK; Kim TH; Han TS; Kim KS; Yim H
J Comput Assist Tomogr; 2013; 37(3):432-9. PubMed ID: 23674017
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
